Market Access
For this Interview with the Innovators series, several interviews were conducted with executives and scientists from Genmab, an international biotech company with 23 years of experience in developing cutting-edge antibodies and antibody technology. The participants discussed a diverse range of topics, including the company’s ability to develop products at scale to serve the entire range of stakeholders in the healthcare ecosystem, the importance of Genmab’s data- and science-driven approach to research, and the innovative corporate culture at the heart of the company’s evolution.